For instance, targeted nanovesicles loaded with siRNA against PD-L1 in CCA cells improved T-cell cytotoxicity when delivered via EpCAM-directed carriers, highlighting the translational potential of nanoscale delivery in biliary tumors (175). This evidence concerns the gene CD274 and cholangiocarcinoma.